Mackay Shields LLC’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-3,400
| Closed | -$411K | – | 150 |
|
|
2023
Q1 | $411K | Hold |
3,400
| – | – | 0.01% | 135 |
|
|
2022
Q4 | $391K | Hold |
3,400
| – | – | 0.01% | 152 |
|
|
2022
Q3 | $349K | Sell |
3,400
-21
| -0.6% | -$2.16K | 0.01% | 155 |
|
|
2022
Q2 | $348K | Buy |
3,421
+21
| +0.6% | +$2.14K | 0.01% | 158 |
|
|
2022
Q1 | $396K | Hold |
3,400
| – | – | ﹤0.01% | 651 |
|
|
2021
Q4 | $388K | Buy |
+3,400
| New | +$388K | ﹤0.01% | 644 |
|
|
2020
Q4 | – | Sell |
-3,400
| Closed | -$379K | – | 1620 |
|
|
2020
Q3 | $379K | Buy |
+3,400
| New | +$379K | ﹤0.01% | 1233 |
|